Chugai is transforming its own business to provide healthcare solutions that will change the society by using digital technology.
UPDATES
- Apr 01, 2024
- “The Digital Transformation Stocks (DX Stocks) 2024 edition” has been announced. Our company has been selected as a “DX Platinum Company 2023-2025”
- Apr 01, 2024
- Takao Suzuki assumed the position of Head of the Digital Transformation Unit.
- Jun 01, 2023
- Chugai Selected as “DX Platinum Companies 2023-2025” in Digital Transformation Stocks (DX Stocks) 2023
VISION
Chugai has set forth “CHUGAI DIGITAL VISION 2030” with a view to 2030.
To realize our VISION, we will transform Chugai Pharmaceutical’s business through three basic strategies and provide healthcare solutions that change society.
![CHUGAI DIGITAL VISION 2030 Transform our business by using digital technologies to make Chugai a top innovator in the provision of society-changing healthcare solutions Three basic strategies 1.Strengthen the digital platform 2.Optimize all value chains 3.Digital transformation for drug discovery and development](/english/profile/digital/index/images/cd_vision01.png?202403)
PEOPLE
Leadership
![](/profile/digital/index/images/cd_leadership01.jpg?202403)
Takao Suzuki
Head of Digital Transformation Unit
![](/profile/digital/index/images/cd_leadership_s1.png?202403)
Head of Digital Transformation Unit
Takao Suzuki
Joined NTT Communications Corporation in 2000. After working on SaaS development and consulting for major corporations, engaged in the architecture and project management of core financial systems in the United States. Upon returning to Japan, served in various roles including Head of Global Sales Strategy, General Manager of the Southern China Base, and Sales Head of Global IT Businesses. In 2018, transitioned to Microsoft to lead the DX Advisory team for global customers in Japan and Asia. Has held the current position since 2024.
![](/profile/digital/index/images/cd_leadership02.jpg?20230105)
Kazumitsu Kanatani
Senior Executive Director, Head of Digital Strategy Department, Digital Transformation Unit
![](/profile/digital/index/images/cd_leadership_s2.png?20230105)
Senior Executive Director, Head of Digital Strategy Department, Digital Transformation Unit
Kazumitsu Kanatani
In 2005, joined clinical development devision. as a member of clinical research associate. I has been responsible for clinical development of Chugai originated products and Roche products for more than 10 years and has contributed regulatory approvals of several products. In 2018, I contributed to established the FMI business in Japan and the insight business in Chugai, which is part of the TOP I 2030 growth strategy. I worked at Genentech as a lead of Personalized Healthcare (PHC) using digital technology. “we lead creating Innovate with digital technology”
![](/profile/digital/index/images/cd_leadership03.jpg)
Keisuke Ohara
Executive Director, Head of IT Solution Department, Digital Transformation Unit
![](/profile/digital/index/images/cd_leadership_s3.png)
Executive Director, Head of IT Solution Department, Digital Transformation Unit
Keisuke Ohara
Joined Nippon Roche in 1994 as a team member of IT infrastructure responsible for APAC region include Japan. In 2002, Keisuke joined Chugai due to a strategic alliance with Roche. In 2008, he was assigned to Roche Pharma Informatics in Basel as a security and application architect. After returning to Chugai, he was appointed head of IT planning group in 2015, and promoted head of IT solution department in 2019.
EVENT
This page introduces event information about CHUGAI DIGITAL.
CAREERS
Chugai is looking for talent to help us harness digital technology to become a leading innovator in the healthcare industry.